The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Optogenetic Retinal Gene Therapy Market Research Report 2024
Synopsis
The global Optogenetic Retinal Gene Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Optogenetic Retinal Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Optogenetic Retinal Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Optogenetic Retinal Gene Therapy in Neurological Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Optogenetic Retinal Gene Therapy include Bionic Sight, Nanoscope Therapeutics, GenSight Biologics, Allergan, Ray Therapeutics, Novartis, UgeneX, GenAns Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Optogenetic Retinal Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Optogenetic Retinal Gene Therapy.
The Optogenetic Retinal Gene Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Optogenetic Retinal Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Optogenetic Retinal Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bionic Sight
Nanoscope Therapeutics
GenSight Biologics
Allergan
Ray Therapeutics
Novartis
UgeneX
GenAns Biotechnology
Segment by Type
Light Sensitive Protein
Light Sensitive Protein Transporter
Light Stimulation System
Segment by Application
Neurological Diseases
Retinal Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Optogenetic Retinal Gene Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Optogenetic Retinal Gene Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Optogenetic Retinal Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Optogenetic Retinal Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Optogenetic Retinal Gene Therapy in Neurological Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Optogenetic Retinal Gene Therapy include Bionic Sight, Nanoscope Therapeutics, GenSight Biologics, Allergan, Ray Therapeutics, Novartis, UgeneX, GenAns Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Optogenetic Retinal Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Optogenetic Retinal Gene Therapy.
The Optogenetic Retinal Gene Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Optogenetic Retinal Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Optogenetic Retinal Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bionic Sight
Nanoscope Therapeutics
GenSight Biologics
Allergan
Ray Therapeutics
Novartis
UgeneX
GenAns Biotechnology
Segment by Type
Light Sensitive Protein
Light Sensitive Protein Transporter
Light Stimulation System
Segment by Application
Neurological Diseases
Retinal Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Optogenetic Retinal Gene Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Optogenetic Retinal Gene Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Light Sensitive Protein
1.2.3 Light Sensitive Protein Transporter
1.2.4 Light Stimulation System
1.3 Market by Application
1.3.1 Global Optogenetic Retinal Gene Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Neurological Diseases
1.3.3 Retinal Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Optogenetic Retinal Gene Therapy Market Perspective (2019-2030)
2.2 Global Optogenetic Retinal Gene Therapy Growth Trends by Region
2.2.1 Global Optogenetic Retinal Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Optogenetic Retinal Gene Therapy Historic Market Size by Region (2019-2024)
2.2.3 Optogenetic Retinal Gene Therapy Forecasted Market Size by Region (2025-2030)
2.3 Optogenetic Retinal Gene Therapy Market Dynamics
2.3.1 Optogenetic Retinal Gene Therapy Industry Trends
2.3.2 Optogenetic Retinal Gene Therapy Market Drivers
2.3.3 Optogenetic Retinal Gene Therapy Market Challenges
2.3.4 Optogenetic Retinal Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Optogenetic Retinal Gene Therapy Players by Revenue
3.1.1 Global Top Optogenetic Retinal Gene Therapy Players by Revenue (2019-2024)
3.1.2 Global Optogenetic Retinal Gene Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Optogenetic Retinal Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Optogenetic Retinal Gene Therapy Revenue
3.4 Global Optogenetic Retinal Gene Therapy Market Concentration Ratio
3.4.1 Global Optogenetic Retinal Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Optogenetic Retinal Gene Therapy Revenue in 2023
3.5 Global Key Players of Optogenetic Retinal Gene Therapy Head office and Area Served
3.6 Global Key Players of Optogenetic Retinal Gene Therapy, Product and Application
3.7 Global Key Players of Optogenetic Retinal Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Optogenetic Retinal Gene Therapy Breakdown Data by Type
4.1 Global Optogenetic Retinal Gene Therapy Historic Market Size by Type (2019-2024)
4.2 Global Optogenetic Retinal Gene Therapy Forecasted Market Size by Type (2025-2030)
5 Optogenetic Retinal Gene Therapy Breakdown Data by Application
5.1 Global Optogenetic Retinal Gene Therapy Historic Market Size by Application (2019-2024)
5.2 Global Optogenetic Retinal Gene Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Optogenetic Retinal Gene Therapy Market Size (2019-2030)
6.2 North America Optogenetic Retinal Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Optogenetic Retinal Gene Therapy Market Size by Country (2019-2024)
6.4 North America Optogenetic Retinal Gene Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Optogenetic Retinal Gene Therapy Market Size (2019-2030)
7.2 Europe Optogenetic Retinal Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Optogenetic Retinal Gene Therapy Market Size by Country (2019-2024)
7.4 Europe Optogenetic Retinal Gene Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Optogenetic Retinal Gene Therapy Market Size (2019-2030)
8.2 Asia-Pacific Optogenetic Retinal Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Optogenetic Retinal Gene Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Optogenetic Retinal Gene Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Optogenetic Retinal Gene Therapy Market Size (2019-2030)
9.2 Latin America Optogenetic Retinal Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Optogenetic Retinal Gene Therapy Market Size by Country (2019-2024)
9.4 Latin America Optogenetic Retinal Gene Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Optogenetic Retinal Gene Therapy Market Size (2019-2030)
10.2 Middle East & Africa Optogenetic Retinal Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Optogenetic Retinal Gene Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Optogenetic Retinal Gene Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bionic Sight
11.1.1 Bionic Sight Company Details
11.1.2 Bionic Sight Business Overview
11.1.3 Bionic Sight Optogenetic Retinal Gene Therapy Introduction
11.1.4 Bionic Sight Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024)
11.1.5 Bionic Sight Recent Development
11.2 Nanoscope Therapeutics
11.2.1 Nanoscope Therapeutics Company Details
11.2.2 Nanoscope Therapeutics Business Overview
11.2.3 Nanoscope Therapeutics Optogenetic Retinal Gene Therapy Introduction
11.2.4 Nanoscope Therapeutics Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024)
11.2.5 Nanoscope Therapeutics Recent Development
11.3 GenSight Biologics
11.3.1 GenSight Biologics Company Details
11.3.2 GenSight Biologics Business Overview
11.3.3 GenSight Biologics Optogenetic Retinal Gene Therapy Introduction
11.3.4 GenSight Biologics Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024)
11.3.5 GenSight Biologics Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Optogenetic Retinal Gene Therapy Introduction
11.4.4 Allergan Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024)
11.4.5 Allergan Recent Development
11.5 Ray Therapeutics
11.5.1 Ray Therapeutics Company Details
11.5.2 Ray Therapeutics Business Overview
11.5.3 Ray Therapeutics Optogenetic Retinal Gene Therapy Introduction
11.5.4 Ray Therapeutics Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024)
11.5.5 Ray Therapeutics Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Optogenetic Retinal Gene Therapy Introduction
11.6.4 Novartis Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 UgeneX
11.7.1 UgeneX Company Details
11.7.2 UgeneX Business Overview
11.7.3 UgeneX Optogenetic Retinal Gene Therapy Introduction
11.7.4 UgeneX Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024)
11.7.5 UgeneX Recent Development
11.8 GenAns Biotechnology
11.8.1 GenAns Biotechnology Company Details
11.8.2 GenAns Biotechnology Business Overview
11.8.3 GenAns Biotechnology Optogenetic Retinal Gene Therapy Introduction
11.8.4 GenAns Biotechnology Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024)
11.8.5 GenAns Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Optogenetic Retinal Gene Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Light Sensitive Protein
Table 3. Key Players of Light Sensitive Protein Transporter
Table 4. Key Players of Light Stimulation System
Table 5. Global Optogenetic Retinal Gene Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Optogenetic Retinal Gene Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Optogenetic Retinal Gene Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Optogenetic Retinal Gene Therapy Market Share by Region (2019-2024)
Table 9. Global Optogenetic Retinal Gene Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Optogenetic Retinal Gene Therapy Market Share by Region (2025-2030)
Table 11. Optogenetic Retinal Gene Therapy Market Trends
Table 12. Optogenetic Retinal Gene Therapy Market Drivers
Table 13. Optogenetic Retinal Gene Therapy Market Challenges
Table 14. Optogenetic Retinal Gene Therapy Market Restraints
Table 15. Global Optogenetic Retinal Gene Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Optogenetic Retinal Gene Therapy Market Share by Players (2019-2024)
Table 17. Global Top Optogenetic Retinal Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Optogenetic Retinal Gene Therapy as of 2023)
Table 18. Ranking of Global Top Optogenetic Retinal Gene Therapy Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Optogenetic Retinal Gene Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Optogenetic Retinal Gene Therapy, Headquarters and Area Served
Table 21. Global Key Players of Optogenetic Retinal Gene Therapy, Product and Application
Table 22. Global Key Players of Optogenetic Retinal Gene Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Optogenetic Retinal Gene Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Optogenetic Retinal Gene Therapy Revenue Market Share by Type (2019-2024)
Table 26. Global Optogenetic Retinal Gene Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Optogenetic Retinal Gene Therapy Revenue Market Share by Type (2025-2030)
Table 28. Global Optogenetic Retinal Gene Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Optogenetic Retinal Gene Therapy Revenue Market Share by Application (2019-2024)
Table 30. Global Optogenetic Retinal Gene Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Optogenetic Retinal Gene Therapy Revenue Market Share by Application (2025-2030)
Table 32. North America Optogenetic Retinal Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Optogenetic Retinal Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Optogenetic Retinal Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Optogenetic Retinal Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Optogenetic Retinal Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Optogenetic Retinal Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Optogenetic Retinal Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Optogenetic Retinal Gene Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Optogenetic Retinal Gene Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Optogenetic Retinal Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Optogenetic Retinal Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Optogenetic Retinal Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Optogenetic Retinal Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Optogenetic Retinal Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Optogenetic Retinal Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bionic Sight Company Details
Table 48. Bionic Sight Business Overview
Table 49. Bionic Sight Optogenetic Retinal Gene Therapy Product
Table 50. Bionic Sight Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024) & (US$ Million)
Table 51. Bionic Sight Recent Development
Table 52. Nanoscope Therapeutics Company Details
Table 53. Nanoscope Therapeutics Business Overview
Table 54. Nanoscope Therapeutics Optogenetic Retinal Gene Therapy Product
Table 55. Nanoscope Therapeutics Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024) & (US$ Million)
Table 56. Nanoscope Therapeutics Recent Development
Table 57. GenSight Biologics Company Details
Table 58. GenSight Biologics Business Overview
Table 59. GenSight Biologics Optogenetic Retinal Gene Therapy Product
Table 60. GenSight Biologics Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024) & (US$ Million)
Table 61. GenSight Biologics Recent Development
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Optogenetic Retinal Gene Therapy Product
Table 65. Allergan Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024) & (US$ Million)
Table 66. Allergan Recent Development
Table 67. Ray Therapeutics Company Details
Table 68. Ray Therapeutics Business Overview
Table 69. Ray Therapeutics Optogenetic Retinal Gene Therapy Product
Table 70. Ray Therapeutics Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024) & (US$ Million)
Table 71. Ray Therapeutics Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Optogenetic Retinal Gene Therapy Product
Table 75. Novartis Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. UgeneX Company Details
Table 78. UgeneX Business Overview
Table 79. UgeneX Optogenetic Retinal Gene Therapy Product
Table 80. UgeneX Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024) & (US$ Million)
Table 81. UgeneX Recent Development
Table 82. GenAns Biotechnology Company Details
Table 83. GenAns Biotechnology Business Overview
Table 84. GenAns Biotechnology Optogenetic Retinal Gene Therapy Product
Table 85. GenAns Biotechnology Revenue in Optogenetic Retinal Gene Therapy Business (2019-2024) & (US$ Million)
Table 86. GenAns Biotechnology Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Optogenetic Retinal Gene Therapy Picture
Figure 2. Global Optogenetic Retinal Gene Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Optogenetic Retinal Gene Therapy Market Share by Type: 2023 VS 2030
Figure 4. Light Sensitive Protein Features
Figure 5. Light Sensitive Protein Transporter Features
Figure 6. Light Stimulation System Features
Figure 7. Global Optogenetic Retinal Gene Therapy Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Optogenetic Retinal Gene Therapy Market Share by Application: 2023 VS 2030
Figure 9. Neurological Diseases Case Studies
Figure 10. Retinal Diseases Case Studies
Figure 11. Others Case Studies
Figure 12. Optogenetic Retinal Gene Therapy Report Years Considered
Figure 13. Global Optogenetic Retinal Gene Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Optogenetic Retinal Gene Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Optogenetic Retinal Gene Therapy Market Share by Region: 2023 VS 2030
Figure 16. Global Optogenetic Retinal Gene Therapy Market Share by Players in 2023
Figure 17. Global Top Optogenetic Retinal Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Optogenetic Retinal Gene Therapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Optogenetic Retinal Gene Therapy Revenue in 2023
Figure 19. North America Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Optogenetic Retinal Gene Therapy Market Share by Country (2019-2030)
Figure 21. United States Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Optogenetic Retinal Gene Therapy Market Share by Country (2019-2030)
Figure 25. Germany Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Optogenetic Retinal Gene Therapy Market Share by Region (2019-2030)
Figure 33. China Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Optogenetic Retinal Gene Therapy Market Share by Country (2019-2030)
Figure 41. Mexico Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Optogenetic Retinal Gene Therapy Market Share by Country (2019-2030)
Figure 45. Turkey Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. UAE Optogenetic Retinal Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Bionic Sight Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2019-2024)
Figure 49. Nanoscope Therapeutics Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2019-2024)
Figure 50. GenSight Biologics Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2019-2024)
Figure 51. Allergan Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2019-2024)
Figure 52. Ray Therapeutics Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2019-2024)
Figure 53. Novartis Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2019-2024)
Figure 54. UgeneX Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2019-2024)
Figure 55. GenAns Biotechnology Revenue Growth Rate in Optogenetic Retinal Gene Therapy Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
